市場調査レポート

商品コード

1797897

バイオハッキングの世界市場：将来予測 (2032年まで) - 製品別・用途別・エンドユーザー別・地域別の分析

Biohacking Market Forecasts to 2032 - Global Analysis By Product (Wearables, Implants, Gene Modification Kits, Smart Drugs (Nootropics), Supplements, Mobile Applications and Other Products), Application, End User and By Geography

出版日: 2025年08月07日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 615,362円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 778,470円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 941,578円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,112,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.28円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界のバイオハッキング市場は2025年に300億1,000万米ドルを占め、2032年には1,119億8,000万米ドルに達すると予測され、予測期間中のCAGRは20.7％です。

バイオハッキングは、生物学、テクノロジー、自己実験を活用することで肉体的・精神的パフォーマンスを向上させる生活様式であり、科学です。健康と長寿を最大化するために、向精神薬、遺伝的洞察、ウェアラブル技術、運動、栄養を統合します。遺伝子編集や埋め込み型デバイスのような高度な方法を試すバイオハッカーがいる一方で、瞑想や睡眠追跡、断続的断食のような、よりわかりやすい調整に集中する人もいます。回復力、エネルギー、集中力を高めるために身体のシステムを理解し、改善することが目的です。バイオハッキングには潜在的な利点がありますが、特に規制のない方法で行われる場合には、道徳的な問題や安全保障上の問題もあります。バイオハッキングを適切に使えば、人々は自分の生物学を管理できるようになります。

世界保健機関（WHO）によれば、健康モニタリングを可能にするウェアラブルを含むデジタルヘルス技術は、医療システムの効率性、持続可能性、医療への公平なアクセスを改善するための重要なツールであると考えられています。WHOのデジタルヘルスに関する世界戦略（2020～2025年）は、世界中でこの可能性を強調しています。

予防医療、個別化医療への関心の高まり

バイオハッキング市場を推進する主な要因の一つは、事後対応型ヘルスケアから事前対応型ヘルスケアへの移行が進んでいることです。糖尿病、肥満、心血管障害、神経変性疾患などの慢性疾患に対する意識の高まりから、消費者は問題が悪化する前に健康を管理するようになっています。持続グルコースモニター（CGM）、ウェアラブルトラッカー、マイクロバイオーム検査キット、DNA分析サービスは、早期発見と個別の介入計画を促進するバイオハックツールの一例です。さらに、自己最適化、カスタマイズされた栄養計画、サプリメント療法は、ストレスが多く、座りっぱなしの習慣があり、食生活が乱れている現代のライフスタイルのため、より一般的になってきています。

健康被害と安全性の問題

バイオハッキングは画期的な成果を約束しますが、多くの介入法には長期的な安全性データがないため、重大な健康リスクがあります。監視のない向精神薬の使用、証明されていない幹細胞治療、家庭での遺伝子編集などの実験的な方法によって、予測できない副作用が生じる可能性があります。これらの副作用は、軽度のアレルギー反応から深刻な生理学的問題にまで及ぶ可能性があります。医学的な監督なしに、ユーザーは古い、あるいは誤ったオンラインの説明書を使ってデバイスを取り付けたり、薬剤を自己投与したりすることが多いです。さらに、バイオハッキング・イノベーションは、安全性を保証するために必要な臨床研究よりも早く進歩することが多いため、消費者は初期段階の被験者となります。

従来型医療への組み入れが進む

バイオハッキングテクノロジーは、医療が個別化医療や予防医療に向かうにつれて、クリニック、病院、遠隔医療プラットフォームと統合する大きなチャンスがあります。従来の診断に加え、ウェアラブル技術、遺伝子検査、マイクロバイオーム解析は、医師が個別の治療レジメンを作成するのに役立ちます。ウェルネス・イニシアチブの一環として、特に慢性疾患を回避することで長期的な医療費を削減できるのであれば、最終的には保険会社がバイオハッキングツールの一部を負担することになるかもしれません。医療提供者ーとバイオハッキングビジネスのコラボレーションは、規制遵守と信頼性を向上させる可能性もあります。バイオハッキングは"ニッチ"なイメージを払拭し、エビデンスに基づく医療行為と融合することで、現代の医療システムの一部として受け入れられるようになります。

サイバーセキュリティとデータプライバシーへのリスク

バイオハッキング技術によって、遺伝子情報、生体測定値、生活習慣パターンなど、大量の個人健康機密データが生成されます。このデータの保護が不十分なため、個人情報の盗難、サイバー攻撃、第三者による不正利用などの被害を受けやすいです。業界全体に対する消費者の信頼は、プライバシー侵害によって損なわれる可能性があり、これは深刻な倫理的、法的、風評的影響をもたらす可能性があります。バイオハッキングツールがクラウドプラットフォームやモバイルアプリと統合されるにつれて、企業はGDPRやHIPAAといった国際的なデータ保護規制を遵守する必要に迫られています。さらに、効果的でないユーザーデータセキュリティは、政府からの罰金だけでなく、コネクテッドヘルス・サービスを利用する見込みのあるユーザーの意欲を削ぐ結果になりかねません。

COVID-19の影響：

バイオハッキング市場は、COVID-19の大流行時に、人々の関心が一般的な健康状態や免疫システムの改善に移ったため、急激に関心が高まりました。ウェアラブルヘルス技術、遠隔モニタリング・ツール、個別化された健康データは、ロックダウンや社会的距離を置く措置の結果、自宅でフィットネスやメンタルヘルスを管理する上でより重要になりました。さらに、パンデミックによって従来の医療システムの欠陥が露呈し、バイオハッキングの自己管理型・予防型ヘルスソリューションへの需要が高まりました。しかし、製品の発売や技術革新は、サプライチェーンの中断や規制当局の差し止めによって一時的に停滞しました。最終的には、テクノロジーを駆使したプロアクティブな健康管理を目指す大きな動きの一環として、COVID-19が触媒の役割を果たし、バイオハッキングテクノロジーの認知度と採用率が高まりました。

予測期間中、ウェアラブル・セグメントが最大となる見込み

予測期間中、ウェアラブルセグメントが最大の市場シェアを占めると予想されます。バイオハッキングの市場は、消費者に広くアピールし、アクセスしやすく、技術革新が進んでいるウェアラブルが支配的です。これらのガジェット（EEGヘッドバンド、スマートウォッチ、フィットネストラッカー、持続グルコースモニターなど）は、リアルタイムの生体データを提供し、ユーザーがストレス、心拍数、活動レベル、睡眠の質などの健康指標を追跡し、改善することを可能にします。さらに、IoT機能を備えたウェアラブルの利用が拡大し、センサーの精度やバッテリー寿命が向上した結果、市場が拡大しています。多くの人がウェアラブルでバイオハッキングを始めており、気軽な健康追跡と高度な自己最適化のギャップを埋めており、世界的に圧倒的な市場シェアの一因となっています。

予測期間中、遺伝子工学分野のCAGRが最も高くなる見込み

予測期間中、遺伝子工学分野は、CRISPRのような遺伝子編集技術の進歩により、最も高い成長率を示すと予測されます。CRISPRは、健康の最適化、病気の予防、強化の目的でDNAを正確に改変することを可能にし、遺伝子工学は急速に発展しています。個別化医療への投資拡大、遺伝子治療への需要拡大、合成生物学技術の利用拡大が、このセグメントの成長の主な促進要因です。さらに、遺伝子工学はバイオハッキングの基本的な要素として急成長が予想され、人間の潜在能力と健康成果を高めることを目的とした次世代バイオハッキング・ソリューションの促進において重要な役割を果たすことが実証されています。

最大のシェアを占める地域

予測期間中、北米地域が最大の市場シェアを占めると予想されます。最先端技術の高い採用率、バイオテクノロジー研究への多額の投資、バイオハッキングイノベーションに集中するトップ企業の強固な基盤、洗練された医療インフラの存在などが、この優位性の要因となっています。米国とカナダでは、個別化医療、健康の最適化、予防医療に対する消費者の意識が高まっており、さまざまなバイオハッキング・アプリケーションに対する需要も高まっています。さらに、北米はバイオハッキングの世界では最大かつ最も発展した市場であり、この地位は有利な規制の枠組みとバイオテクノロジー新興企業への多額の資金提供によってさらに支えられています。

CAGRが最も高い地域：

予測期間中、アジア太平洋が最も高いCAGRを示すと予測されています。中国、インド、日本、韓国などの国々における医療支出の増加、個別化された健康とウェルネスに対する意識の高まり、バイオテクノロジーとライフサイエンスへの投資の拡大が、この急成長の主な要因です。市場のダイナミックな拡大は、可処分所得を持つ中間層の拡大、予防医療重視の高まり、バイオハッキングの進歩も後押ししています。さらに、アジア太平洋はこの市場の成長率が最も高い地域ですが、これは同地域の政府もバイオテクノロジー研究開発に資金を提供しており、バイオハッキングテクノロジーの採用を加速させているためです。

無料のカスタマイズサービス

当レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域区分
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東・アフリカ

第9章主な動向

契約、事業提携・協力、合弁事業
企業合併・買収 (M&A)
新製品の発売
事業拡張
その他の主要戦略

第10章企業プロファイリング

Halo Neuroscience
Apple Inc.
HVMN, Inc
Bulletproof Inc
InteraXon Inc.
Fitbit, Inc.
Moodmetric
Dexcom
Oura Health Oy
Abbott Laboratories
Osteostrong
Thriveport LLC
Synthego
Nightingale Health Ltd.
Thync Global, Inc.

図表

List of Tables

Table 1 Global Biohacking Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 3 Global Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 4 Global Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 5 Global Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 6 Global Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 7 Global Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 8 Global Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 9 Global Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 10 Global Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 11 Global Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 12 Global Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 13 Global Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 14 Global Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 15 Global Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 16 Global Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 17 Global Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 18 Global Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 19 Global Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 20 Global Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 21 Global Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 22 Global Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 23 North America Biohacking Market Outlook, By Country (2024-2032) ($MN)
Table 24 North America Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 25 North America Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 26 North America Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 27 North America Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 28 North America Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 29 North America Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 30 North America Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 31 North America Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 32 North America Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 33 North America Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 34 North America Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 35 North America Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 36 North America Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 37 North America Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 38 North America Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 39 North America Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 40 North America Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 41 North America Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 42 North America Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 43 North America Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 44 North America Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 45 Europe Biohacking Market Outlook, By Country (2024-2032) ($MN)
Table 46 Europe Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 47 Europe Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 48 Europe Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 49 Europe Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 50 Europe Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 51 Europe Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 52 Europe Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 53 Europe Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 54 Europe Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 55 Europe Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 56 Europe Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 57 Europe Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 58 Europe Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 59 Europe Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 60 Europe Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 61 Europe Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 62 Europe Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 63 Europe Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 64 Europe Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 65 Europe Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 66 Europe Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 67 Asia Pacific Biohacking Market Outlook, By Country (2024-2032) ($MN)
Table 68 Asia Pacific Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 69 Asia Pacific Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 70 Asia Pacific Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 71 Asia Pacific Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 72 Asia Pacific Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 73 Asia Pacific Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 74 Asia Pacific Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 75 Asia Pacific Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 76 Asia Pacific Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 77 Asia Pacific Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 78 Asia Pacific Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 79 Asia Pacific Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 80 Asia Pacific Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 81 Asia Pacific Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 82 Asia Pacific Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 83 Asia Pacific Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 84 Asia Pacific Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 85 Asia Pacific Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 86 Asia Pacific Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 87 Asia Pacific Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 88 Asia Pacific Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 89 South America Biohacking Market Outlook, By Country (2024-2032) ($MN)
Table 90 South America Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 91 South America Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 92 South America Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 93 South America Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 94 South America Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 95 South America Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 96 South America Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 97 South America Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 98 South America Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 99 South America Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 100 South America Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 101 South America Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 102 South America Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 103 South America Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 104 South America Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 105 South America Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 106 South America Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 107 South America Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 108 South America Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 109 South America Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 110 South America Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 111 Middle East & Africa Biohacking Market Outlook, By Country (2024-2032) ($MN)
Table 112 Middle East & Africa Biohacking Market Outlook, By Product (2024-2032) ($MN)
Table 113 Middle East & Africa Biohacking Market Outlook, By Wearables (2024-2032) ($MN)
Table 114 Middle East & Africa Biohacking Market Outlook, By Implants (2024-2032) ($MN)
Table 115 Middle East & Africa Biohacking Market Outlook, By Gene Modification Kits (2024-2032) ($MN)
Table 116 Middle East & Africa Biohacking Market Outlook, By Smart Drugs (Nootropics) (2024-2032) ($MN)
Table 117 Middle East & Africa Biohacking Market Outlook, By Supplements (2024-2032) ($MN)
Table 118 Middle East & Africa Biohacking Market Outlook, By Mobile Applications (2024-2032) ($MN)
Table 119 Middle East & Africa Biohacking Market Outlook, By Other Products (2024-2032) ($MN)
Table 120 Middle East & Africa Biohacking Market Outlook, By Application (2024-2032) ($MN)
Table 121 Middle East & Africa Biohacking Market Outlook, By Synthetic Biology (2024-2032) ($MN)
Table 122 Middle East & Africa Biohacking Market Outlook, By Genetic Engineering (2024-2032) ($MN)
Table 123 Middle East & Africa Biohacking Market Outlook, By Forensic Science (2024-2032) ($MN)
Table 124 Middle East & Africa Biohacking Market Outlook, By Diagnosis & Treatment (2024-2032) ($MN)
Table 125 Middle East & Africa Biohacking Market Outlook, By Drug Testing (2024-2032) ($MN)
Table 126 Middle East & Africa Biohacking Market Outlook, By End User (2024-2032) ($MN)
Table 127 Middle East & Africa Biohacking Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 128 Middle East & Africa Biohacking Market Outlook, By General Population / Consumers (2024-2032) ($MN)
Table 129 Middle East & Africa Biohacking Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 130 Middle East & Africa Biohacking Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
Table 131 Middle East & Africa Biohacking Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
Table 132 Middle East & Africa Biohacking Market Outlook, By Other End Users (2024-2032) ($MN)

Product Code: SMRC30267

According to Stratistics MRC, the Global Biohacking Market is accounted for $30.01 billion in 2025 and is expected to reach $111.98 billion by 2032 growing at a CAGR of 20.7% during the forecast period. Biohacking is a way of life and science in which people improve their physical and mental performance by utilizing biology, technology, and self-experimentation. To maximize health and longevity, it integrates nootropics, genetic insights, wearable technology, exercise, and nutrition. While some biohackers experiment with more sophisticated methods like gene editing or implanted devices, others concentrate on more straightforward adjustments like meditation, sleep tracking, or intermittent fasting. Understanding and improving the body's systems for increased resilience, energy, and focus is the aim. Although biohacking has potential advantages, it also presents moral and security issues, particularly when done in an unregulated manner. When used properly, it gives people the ability to take charge of their biology.

According to the World Health Organization (WHO), digital health technologies-including wearable's that enable health monitoring-are seen as crucial tools for improving health systems' efficiency, sustainability, and equitable access to care. WHO's 2020-2025 Global Strategy on Digital Health underscores this potential around the world.

Market Dynamics:

Driver:

Growing interest in preventive, personalized health

One of the main factors propelling the biohacking market is the increasing transition from reactive to proactive healthcare. Consumers are taking charge of their health before problems worsen as a result of growing awareness of chronic conditions like diabetes, obesity, cardiovascular disorders, and neurodegenerative diseases. Continuous glucose monitors (CGMs), wearable trackers, microbiome testing kits, and DNA analysis services are examples of biohacking tools that facilitate early detection and individualized intervention plans. Furthermore, self-optimization, customized nutrition plans, and supplementation regimens have become more popular due to the modern lifestyle's high levels of stress, sedentary habits, and poor diets.

Restraint:

Health hazards and safety issues

Although biohacking promises revolutionary outcomes, there are significant health risks due to the lack of long-term safety data for many interventions. Unpredictable side effects can result from experimental procedures like unsupervised nootropic use, unproven stem cell therapies, and at-home gene editing. These can range from mild allergic reactions to serious physiological issues. Without medical supervision, users frequently install devices or self-administer drugs using outdated or erroneous online instructions. Furthermore, consumers serve as early-stage test subjects because biohacking innovation frequently advances faster than the clinical research required to guarantee safety.

Opportunity:

Increasing incorporation into conventional healthcare

Biohacking technologies have a great chance to integrate with clinics, hospitals, and telehealth platforms as healthcare moves toward personalized and preventive medicine. In addition to conventional diagnostics, wearable technology, genetic testing, and microbiome analysis can help physicians create individualized treatment regimens. As part of wellness initiatives, insurance companies may eventually pay for some biohacking tools, particularly if they lower long-term medical expenses by averting chronic illnesses. Collaborations between healthcare providers and biohacking businesses may also improve regulatory compliance and credibility. Biohacking can lose its "niche" image and become accepted as a part of contemporary health systems by integrating with evidence-based medical practices, which will open up a wide range of new market niches.

Threat:

Risks to cybersecurity and data privacy

Large volumes of sensitive personal health data, such as genetic information, biometric readings, and lifestyle patterns, are produced by biohacking technologies. Inadequate protection of this data makes it vulnerable to identity theft, cyberattacks, and unauthorized third-party use. Consumer confidence in the industry as a whole can be damaged by privacy violations, which can have serious ethical, legal, and reputational repercussions. Businesses are under increasing pressure to abide by international data protection regulations like GDPR and HIPAA as biohacking tools become more integrated with cloud platforms and mobile apps. Moreover, ineffective user data security may result in fines from the government as well as discourage prospective users from utilizing connected health services.

Covid-19 Impact:

The market for biohacking saw a sharp increase in interest during the COVID-19 pandemic as people's attention shifted to improving their general health and immune systems. Wearable health technology, remote monitoring tools, and personalized health data have become more important for managing fitness and mental health from home as a result of lockdowns and social distancing measures. Furthermore, the pandemic exposed flaws in conventional healthcare systems, which increased demand for bio hacking's self-managed and preventive health solutions. Product launches and innovation were, however, momentarily slowed by supply chain interruptions and regulatory hold-ups. Ultimately, as part of a larger movement toward proactive, tech-enabled health management, COVID-19 served as a catalyst, increasing awareness and adoption of biohacking technologies.

The wearables segment is expected to be the largest during the forecast period

The wearables segment is expected to account for the largest market share during the forecast period. The market for biohacking is dominated by wearables because of their widespread consumer appeal, accessibility, and ongoing innovation. These gadgets-which include EEG headbands, smart watches, fitness trackers, and continuous glucose monitors-provide real-time biometric data that enables users to track and improve health indicators like stress, heart rate, activity levels, and sleep quality. Moreover, the market has grown as a result of the growing use of wearables with IoT capabilities as well as improvements in sensor precision and battery life. Many people begin biohacking with wearables, which bridge the gap between casual health tracking and sophisticated self-optimization and help explain their dominant market share worldwide.

The genetic engineering segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the genetic engineering segment is predicted to witness the highest growth rate due to advancements in gene editing technologies like CRISPR, which allow for precise DNA modifications for health optimization, disease prevention, and enhancement purposes, genetic engineering is developing quickly. Growing investments in personalized medicine, growing demand for gene therapies, and growing uses of synthetic biology techniques are the main drivers of this segment's growth. Additionally, genetic engineering is anticipated to grow rapidly as a fundamental component of biohacking, demonstrating its vital role in facilitating next-generation biohacking solutions aimed at enhancing human potential and health results.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. High adoption of cutting-edge technologies, substantial investments in biotech research, a robust base of top companies concentrating on biohacking innovations, and the existence of sophisticated healthcare infrastructure are all factors contributing to this dominance. In the United States and Canada, rising consumer awareness of personalized medicine, health optimization, and preventive healthcare also increases demand for a variety of biohacking applications. Furthermore, North America is the largest and most developed market in the world of biohacking, and this position is further supported by favorable regulatory frameworks and substantial funding for biotech startups.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR. Growing healthcare spending, growing awareness of individualized health and wellness, and growing investments in biotechnology and life sciences in nations like China, India, Japan, and South Korea are the main drivers of this quick growth. The market's dynamic expansion is also aided by an expanding middle class with disposable income, a growing emphasis on preventive healthcare, and advancements in biohacking. Moreover, Asia-Pacific is the region with the fastest rate of growth in this market because governments there are also funding biotech research and development, which speeds up the adoption of biohacking technologies.

Key players in the market

Some of the key players in Biohacking Market include Halo Neuroscience, Apple Inc., HVMN, Inc, Bulletproof Inc, InteraXon Inc., Fitbit, Inc., Moodmetric, Dexcom, Oura Health Oy, Abbott Laboratories, Osteostrong, Thriveport LLC, Synthego, Nightingale Health Ltd. and Thync Global, Inc.

Key Developments:

In August 2025, Apple and Coherent expand strategic partnership with new multiyear VCSEL Agreement in Texas. Under the new agreement, Coherent will continue to produce vertical-cavity surface-emitting lasers (VCSELs) that enable key features such as Face ID on iPhone and iPad devices shipped around the world.

In March 2025, Abbott and Cadrenal sign agreement for LVAD trial of tecarfarin. With Abbott's support, Cadrenal aims to plan and execute the trial, which assesses the safety and efficacy of oral vitamin K antagonist, tecarfarin, in individuals with LVADs, under the partnership and data sharing agreement terms.

In December 2024, DexCom and Abbott Laboratories that they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

Products Covered:

Wearables
Implants
Gene Modification Kits
Smart Drugs (Nootropics)
Supplements
Mobile Applications
Other Products

Applications Covered:

Synthetic Biology
Genetic Engineering
Forensic Science
Diagnosis & Treatment
Drug Testing

End Users Covered:

Pharmaceutical & Biotechnology Companies
General Population / Consumers
Hospitals & Clinics
Forensic Laboratories
Research & Academic Institutes
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biohacking Market, By Product

5.1 Introduction
5.2 Wearables
5.3 Implants
5.4 Gene Modification Kits
5.5 Smart Drugs (Nootropics)
5.6 Supplements
5.7 Mobile Applications
5.8 Other Products

6 Global Biohacking Market, By Application

6.1 Introduction
6.2 Synthetic Biology
6.3 Genetic Engineering
6.4 Forensic Science
6.5 Diagnosis & Treatment
6.6 Drug Testing

7 Global Biohacking Market, By End User

7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.3 General Population / Consumers
7.4 Hospitals & Clinics
7.5 Forensic Laboratories
7.6 Research & Academic Institutes
7.7 Other End Users

8 Global Biohacking Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Halo Neuroscience
10.2 Apple Inc.
10.3 HVMN, Inc
10.4 Bulletproof Inc
10.5 InteraXon Inc.
10.6 Fitbit, Inc.
10.7 Moodmetric
10.8 Dexcom
10.9 Oura Health Oy
10.10 Abbott Laboratories
10.11 Osteostrong
10.12 Thriveport LLC
10.13 Synthego
10.14 Nightingale Health Ltd.
10.15 Thync Global, Inc.

バイオハッキングの世界市場：将来予測 (2032年まで) - 製品別・用途別・エンドユーザー別・地域別の分析

Biohacking Market Forecasts to 2032 - Global Analysis By Product (Wearables, Implants, Gene Modification Kits, Smart Drugs (Nootropics), Supplements, Mobile Applications and Other Products), Application, End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス

当レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序論

第3章 市場動向の分析

第4章 ポーターのファイブフォース分析

第5章 世界のバイオハッキング市場：製品別

第6章 世界のバイオハッキング市場：用途別

第7章 世界のバイオハッキング市場：エンドユーザー別

第8章 世界のバイオハッキング市場：地域別

第9章 主な動向

第10章 企業プロファイリング